Combined systemic beta-interferon and thymostimulin administration for metastatic brain tumors. A brief report.

Department of Neurosurgery, Faculty of Medicine, University of Messina, Italy.
Journal of neurosurgical sciences (Impact Factor: 1.16). 04/1994; 38(1):35-42.
Source: PubMed


Interferon-beta (IFN-B) plus thymostimulin (Th) were administered for eight weeks, intravenously and by intramuscular route to eight patients with metastatic brain tumors. No patient had a complete response. One had a stable disease and seven a progressive disease during that time. The mechanisms of the action of IFN-B and Th, and the possible therapeutic value are discussed.

1 Read